277 related articles for article (PubMed ID: 24649895)
1. Informing relatives about their hereditary or familial cancer risk: study protocol for a randomized controlled trial.
de Geus E; Aalfs CM; Verdam MG; de Haes HC; Smets EM
Trials; 2014 Mar; 15():86. PubMed ID: 24649895
[TBL] [Abstract][Full Text] [Related]
2. How to support cancer genetics counselees in informing at-risk relatives? Lessons from a randomized controlled trial.
Eijzenga W; de Geus E; Aalfs CM; Menko FH; Sijmons RH; de Haes HCJM; Smets EMA
Patient Educ Couns; 2018 Sep; 101(9):1611-1619. PubMed ID: 29789176
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of a standardized questionnaire in facilitating personalized communication about problems encountered in cancer genetic counseling: design of a randomized controlled trial.
Eijzenga W; Aaronson NK; Kluijt I; Sidharta GN; Hahn DE; Ausems MG; Bleiker EM
BMC Cancer; 2014 Jan; 14():26. PubMed ID: 24428912
[TBL] [Abstract][Full Text] [Related]
4. Development of the Informing Relatives Inventory (IRI): Assessing Index Patients' Knowledge, Motivation and Self-Efficacy Regarding the Disclosure of Hereditary Cancer Risk Information to Relatives.
de Geus E; Aalfs CM; Menko FH; Sijmons RH; Verdam MG; de Haes HC; Smets EM
Int J Behav Med; 2015 Aug; 22(4):551-60. PubMed ID: 25515913
[TBL] [Abstract][Full Text] [Related]
5. Design and Feasibility of an Intervention to Support Cancer Genetic Counselees in Informing their At-Risk Relatives.
de Geus E; Eijzenga W; Menko FH; Sijmons RH; de Haes HC; Aalfs CM; Smets EM
J Genet Couns; 2016 Dec; 25(6):1179-1187. PubMed ID: 27103421
[TBL] [Abstract][Full Text] [Related]
6. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
Roshanai AH; Rosenquist R; Lampic C; Nordin K
Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
[TBL] [Abstract][Full Text] [Related]
7. The counselees' self-reported request for psychological help in genetic counseling for hereditary breast/ovarian cancer: not only psychopathology matters.
Vos J; van Asperen CJ; Oosterwijk JC; Menko FH; Collee MJ; Gomez Garcia E; Tibben A
Psychooncology; 2013 Apr; 22(4):902-10. PubMed ID: 22740372
[TBL] [Abstract][Full Text] [Related]
8. A tailored approach towards informing relatives at risk of inherited cardiac conditions: study protocol for a randomised controlled trial.
van den Heuvel LM; Hoedemaekers YM; Baas AF; van Tintelen JP; Smets EMA; Christiaans I
BMJ Open; 2019 Jul; 9(7):e025660. PubMed ID: 31289060
[TBL] [Abstract][Full Text] [Related]
9. BRACAVENIR - impact of a psychoeducational intervention on expectations and coping in young women (aged 18-30 years) exposed to a high familial breast/ovarian cancer risk: study protocol for a randomized controlled trial.
Kwiatkowski F; Dessenne P; Laquet C; Daures JP; Gay-Bellile M; Bignon YJ
Trials; 2016 Oct; 17(1):509. PubMed ID: 27769293
[TBL] [Abstract][Full Text] [Related]
10. Genetic counseling does not fulfill the counselees' need for certainty in hereditary breast/ovarian cancer families: an explorative assessment.
Vos J; Menko FH; Oosterwijk JC; van Asperen CJ; Stiggelbout AM; Tibben A
Psychooncology; 2013 May; 22(5):1167-76. PubMed ID: 22777929
[TBL] [Abstract][Full Text] [Related]
11. Direct letters to relatives at risk of hereditary cancer-study protocol for a multi-center randomized controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study).
Hawranek C; Ehrencrona H; Öfverholm A; Hellquist BN; Rosén A
Trials; 2023 Dec; 24(1):810. PubMed ID: 38105176
[TBL] [Abstract][Full Text] [Related]
12. Effects of a pre-visit educational website on information recall and needs fulfilment in breast cancer genetic counselling, a randomized controlled trial.
Albada A; van Dulmen S; Bensing JM; Ausems MG
Breast Cancer Res; 2012 Mar; 14(2):R37. PubMed ID: 22394647
[TBL] [Abstract][Full Text] [Related]
13. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
[TBL] [Abstract][Full Text] [Related]
14. Facilitated cascade testing (FaCT): a randomized controlled trial.
Nitecki R; Moss HA; Watson CH; Urbauer DL; Melamed A; Lu KH; Lipkin SM; Offit K; Rauh-Hain JA; Frey MK
Int J Gynecol Cancer; 2021 May; 31(5):779-783. PubMed ID: 33443030
[TBL] [Abstract][Full Text] [Related]
15. Exploring the short-term impact of DNA-testing in breast cancer patients: the counselees' perception matters, but the actual BRCA1/2 result does not.
Vos J; Oosterwijk JC; Gomez-Garcia E; Menko FH; Collee MJ; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
Patient Educ Couns; 2012 Feb; 86(2):239-51. PubMed ID: 21684708
[TBL] [Abstract][Full Text] [Related]
16. Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Desmond A; Kurian AW; Gabree M; Mills MA; Anderson MJ; Kobayashi Y; Horick N; Yang S; Shannon KM; Tung N; Ford JM; Lincoln SE; Ellisen LW
JAMA Oncol; 2015 Oct; 1(7):943-51. PubMed ID: 26270727
[TBL] [Abstract][Full Text] [Related]
17. Disclosing cancer genetic information within families: perspectives of counselees and their at-risk relatives.
Hayat Roshanai A; Lampic C; Rosenquist R; Nordin K
Fam Cancer; 2010 Dec; 9(4):669-79. PubMed ID: 20577820
[TBL] [Abstract][Full Text] [Related]
18. Permanence of the information given during oncogenetic counseling to persons at familial risk of breast/ovarian and/or colon cancer.
Kwiatkowski F; Dessenne P; Laquet C; Petit MF; Bignon YJ
Eur J Hum Genet; 2012 Feb; 20(2):141-7. PubMed ID: 21934710
[TBL] [Abstract][Full Text] [Related]
19. MAGENTA (Making Genetic testing accessible): a prospective randomized controlled trial comparing online genetic education and telephone genetic counseling for hereditary cancer genetic testing.
Rayes N; Bowen DJ; Coffin T; Nebgen D; Peterson C; Munsell MF; Gavin K; Lechner R; Crase J; Polinsky D; Romero I; Blank SV; Levine DA; Norquist BM; Swisher EM; Lu KH
BMC Cancer; 2019 Jul; 19(1):648. PubMed ID: 31266460
[TBL] [Abstract][Full Text] [Related]
20. Psychosocial outcomes and counselee satisfaction following genetic counseling for hereditary breast and ovarian cancer: A patient-reported outcome study.
Oberguggenberger A; Sztankay M; Morscher RJ; Sperner-Unterweger B; Weber I; Hubalek M; Kemmler G; Zschocke J; Martini C; Egle D; Dünser M; Gamper E; Meraner V
J Psychosom Res; 2016 Oct; 89():39-45. PubMed ID: 27663109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
